[{"AccountsPayableCurrent_0_Q3_USD":1182000.0,"ProfitLoss_1_Q3_USD":-12941000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":111000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":114929000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":139523000.0,"PrepaidInsurance_0_Q3_USD":1891000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3493000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1248000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":210789000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_3_Q3_USD":277000.0,"ProfitLoss_3_Q3_USD":-33592000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-33550000.0,"OtherAssetsNoncurrent_0_Q3_USD":104000.0,"OtherAssetsCurrent_0_Q3_USD":854000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":188000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":909000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":1066000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q3_USD":931000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":4224000.0,"OperatingLeaseExpense_3_Q3_USD":500000.0,"OperatingIncomeLoss_3_Q3_USD":-33119000.0,"OperatingIncomeLoss_1_Q3_USD":-13057000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-12946000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":5672000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2994000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":9183000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":188000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":65600.0,"StockholdersEquity_0_Q3_USD":255649000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":8.92,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.14,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.45,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.69,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":2.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":1830144.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":5.56,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3694768.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":29574000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":6.49,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1034622.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":18104.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":1335.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":610000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":3.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":770020.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensation_3_Q3_USD":2784000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-76606000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":23655000.0,"OperatingExpenses_3_Q3_USD":33119000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":40669412.0,"OperatingExpenses_1_Q3_USD":13057000.0,"NetIncomeLoss_1_Q3_USD":-12941000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":9722000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":27311000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":27311000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":252000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":735000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":227423000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":227394000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":5000.0,"CommonStockValue_0_Q3_USD":4000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":34000.0,"Assets_0_Q3_USD":261325000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":4333444.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2785000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1054000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1054000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":332222000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":29000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":2678000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":3800000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-378000.0,"AssetsCurrent_0_Q3_USD":258227000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-12946000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-33550000.0,"Depreciation_3_Q3_USD":400000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-30158000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-97108000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":136988000.0,"MarketableSecuritiesUnrealizedGainLoss_3_Q3_USD":42000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q3_USD":-5000.0,"MarketableSecuritiesCurrent_0_Q3_USD":227423000.0,"MarketableSecurities_0_Q3_USD":227400000.0,"LiabilitiesCurrent_0_Q3_USD":4982000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":261325000.0,"Liabilities_0_Q3_USD":5676000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-473000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":116000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2229000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":92000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":1213000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":210000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":9464000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":3874000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":12000000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.33,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.32,"DepreciationDepletionAndAmortization_3_Q3_USD":435000.0,"NetIncomeLoss_3_Q3_USD":-33592000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":25190479.0,"Ticker":"TALS","CIK":"1827506","name":"TALARIS THERAPEUTICS, INC.","OfficialName":"Talaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"360662650.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]